Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information

Supplemental Balance Sheet Information

6 Months Ended

Jun. 30, 2024

Supplemental Balance Sheet Information [Abstract]

4.	Supplemental Balance Sheet Information

Prepaid and Other Assets

Prepaid and other assets consist of the following (in thousands):

	June 30, 2024		December 31, 2023
Prepaids	$	1,027	$	997
Other		87		102
Total prepaids and other assets	$	1,114	$	1,099

Property and Equipment, net

Property and equipment held for use by category are presented in the following table (in thousands):

	June 30, 2024			December 31, 2023
Equipment		20		$	20
Furniture		5			5
Total property and equipment		25			25
Less accumulated depreciation		(25	)		(25	)
Property and equipment, net	$	—		$	—

Depreciation expense was $1,000 and $2,000 during three and six months ended June 30, 2023, respectively. There was no depreciation expense during both the three and six months ended June 30, 2024.

Accrued Expenses

Accrued expenses consist of the following (in thousands):

	June 30,		December 31,
	2024		2023
Payroll	$	427	$	753
Professional services		1,427		591
Research and development services and supplies		1,540		400
Other		96		71
Total	$	3,490	$	1,815